Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.779 USD | +1.30% | +2.50% | +5.99% |
2023 | NGM Biopharmaceuticals Says Phase 2b Trial of Potential Cirrhosis Treatment Meets Primary Endpoint | MT |
2023 | Alpine 4 Holdings, Inc.(NasdaqCM:ALPP) dropped from S&P Global BMI Index | CI |
Turnover - Change in analysts' estimates
EBIT - Change in analysts' estimates
Turnover
EBIT
- Stock Market
- Equities
- ALPP Stock
- Revisions Alpine 4 Holdings, Inc.